Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS
1998 to 2023 Saw Decline in Triplet, Higher-Order Birth Rate
Decline from 193.5 to 73.8 births per 100,000 total births, with largest decline seen from 2009 to 2023
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
Inavolisib leads to significantly longer progression-free survival, with no increase seen in incidence of toxic events
Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome
Sustained response seen up to six months after injection
ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
Hormone replacement therapy also tied to elevated gastrointestinal symptoms and diagnostic testing
Lower Risk for Asthma Seen With Younger Age at Natural Menopause
Hazard ratio of 0.70 reported for risk for asthma with age at natural menopause of 40 to 44 versus 50 to 54 years
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
USPSTF Recommends Screening for Domestic Violence in Pregnant, Postpartum Women
Current evidence is inadequate for assessing balance of benefits, harms of screening for caregiver abuse and neglect in older, vulnerable adults
Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
Findings seen despite similar rates of serious complications to male patients
Guideline-Concordant Care Less Likely With Non-Hispanic Black Race
Findings seen in older patients with breast cancer; non-Hispanic Black patients also less likely to have timely initiation of treatment
